Navigation Links
First-ever symposium brings together military and civilian medical experts
Date:6/22/2008

Rockville, MD The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) and the Uniformed Services University of the Health Sciences (USU) are holding the first-ever USU-HJF Symposiuma meeting for leading military researchers and clinicians to discuss current and future advances in military medical research.

WHAT: USU-HJF Symposium

Experts in their respective research areas will discuss some of the groundbreaking work being undertaken within the DoD medical community to address prevalent health issues facing U.S. service members. Panels will address: trauma/combat casualty care; poasttraumatic stress disorder/traumatic brain injury; infectious diseases; and cancer.

WHO: Panel moderators and participants include:

COL Chester "Trip" Buckenmaier, M.D., Regional Anesthesia at Walter Reed Army Medical Center
Robert J. Ursano, M.D., Center for the Study of Traumatic Stress
COL Nelson Michael, M.D., Ph.D., U.S. Military HIV Research Program
COL George Peoples, M.D., Surgical Oncology at Brooke Army Medical Center
Lee Helman, M.D., National Cancer Institute
H. Clifford Lane, M.D., National Institutes of Health

Keynote address by Kimberly Dozier, CBS News Correspondent and traumatic brain injury survivor

WHEN: Monday, June 30, 2008
8 a.m. - 5 p.m.

WHERE: Bethesda North Marriott Hotel and Conference Center
5701 Marinelli Road
Bethesda, MD 20852


'/>"/>

Contact: Kelly Huegel
khuegel@hjf.org
301-294-7283
Henry M. Jackson Foundation for the Advancement of Military Medicine
Source:Eurekalert

1

GOOD

Page: 1

Related biology news :

1. First-ever study to link increased mortality specifically to carbon dioxide emissions
2. Study finds first-ever genetic animal model of autism
3. First-ever State of the Carbon Cycle Report finds troubling imbalance
4. First-ever study: lack of critical lubricant causes wear in joints
5. York symposium puts focus on chemical weather
6. At Boston symposium, NARSAD researchers report on genes and family traits
7. Decade of the Mind symposium in Iowa to emphasize need for $4 billion in federal support
8. Rockefeller University hosts 2-day evolution symposium, May 1-2, 2008
9. International symposium explores fire suppression economics
10. Symposium on energy research highlights future challenges, opportunities
11. Pioneers in small RNA research to present at UD symposium, April 16

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...is an important crop in many countries of the worl... feed, and industrial materials. It also is consid...ication, molecular evolution, and genome architect... special collection used the first description of ...riguing questions in genetics and plant biology. T...
(Date:11/19/2009)...d Spring Harbor, NY A four-year, multi-institutio...ratory (CSHL) scientists culminated today in publi...al Science revealing in unprecedented detail the...n, as it is commonly called by North American cons... and the most valuable agricultural crop grown in ...
(Date:11/19/2009)... , WALL, N.J., Nov. 19 /PRNewswire-FirstCall/ ...: BKYI), a leader in wireless public safety and fi...ounced that the Special Shareholder Meeting held t...because a quorum was not present. ,, (Logo: ht...OGO) ,, While an impressive 99.3% of the 35 mil...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Prime Therapeutics Hires Jacqueline Chase as Senior Vice President of Human Resources 58137 1Prime Therapeutics Hires Jacqueline Chase as Senior Vice President of Human Resources 58137 2Morphotek 28R 29 Inc Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins 14231 1Morphotek 28R 29 Inc Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins 14231 2MO BIO Laboratories Inc Launches PowerWater 28R 29 RNA Isolation Kit 14226 1MO BIO Laboratories Inc Launches PowerWater 28R 29 RNA Isolation Kit 14226 2
..., WEST LAFAYETTE, Ind. - Purdue University and U...discovered that a type of gene in grain-producing ... that can destroy crops vital for human food suppl...t the same biochemical process protects an entire ...gal pathogen. The naturally occurring disease resi...
..., An experimental biomarker test developed by res...tely detects prostate cancer than any other screen...published in the February 1 issue of Cancer Resear...er Research. , The researchers say a simple urine...rent RNA molecules accurately identified 80 percen...
..., MADISON - When the world,s most powerful partic...ew particles may offer a glimpse of the existence ...m the University of Wisconsin-Madison and the Univ...e signatures left by a new class of particles coul... spatial dimensions predicted by string theory. , ...
Other Biology News:Gene guards grain-producing grasses so people and animals can eat 2Gene guards grain-producing grasses so people and animals can eat 3New, noninvasive prostate cancer test beats PSA in detecting prostate cancer 2New, noninvasive prostate cancer test beats PSA in detecting prostate cancer 3Particle accelerator may reveal shape of alternate dimensions 2
(Date:11/18/2009)... YORK, Nov. 18 Reportlinker.com an...able in its catalogue. ,, Biotechnology Reage.../www.reportlinker.com/p0164375/Biotechnology-Reage...prnewswire&utm_medium=pr&utm_campaign=prne...complex chemical compounds used in a range of biot...
(Date:11/18/2009)... Promega Corporation and SwitchGear Genomics...otein interactions. , Mad... Corporation and SwitchGear Genomics announce a no...ions. Results of a study using the HaloCHIP™...trate the ability to correlate DNA binding events ...
(Date:11/18/2009)...significantly reduces key cardiac enzymes at multi...ted at American Heart Association 2009 Scientific ... Viron Therapeutics Inc., a biotechnology company ...otein therapeutics derived from pathogens, today r...aluating VT-111 (Serp-1), an anti-inflammatory pro...
(Date:11/18/2009)...MORE, Nov. 18 Champions...an oncology drug development company with a predic...e development and enhancing the value of oncology ...ement with Yale University and Southern Research I...er treatment. Scientists from Yale and Southern R...
Breaking Biology Technology:Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 4
...t market,is expected to grow nearly 8% between 200...$528 million as competition intensifies and divers...rvice Markets, a new report by,Kalorama Informatio...table for the last,several years, with one dominan...n the products or technologies. However, the compl...
... for 9:00 a.m. Eastern Time Today to Be Res...T, Calif., Aug. 24 Vermillion, Inc.,formerly Ciph...ounced that it,has entered into securities purchas...t with a group of existing and new investors. Unde...ive approximately $20.5 million,in gross proceeds ...
...nounced,the appointment of Todd R. Nelson, Ph.D., ...Nelson comes to eBioscience from Invitrogen Corpor...e Development. Dr. Nelson will assume the role of...ain as President during a transition period. Nelso... Dr. Nelson commented: "I,m very excited about jo...
Other Biology Technology:DNA Sequencing Equipment Market to Fragment and Grow as Competition, New Technologies Develop 2Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock 2Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock 3Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc. 2
CD14 MicroBeads, non-human primate from Miltenyi Biotec
...d in matrix degradation. Of the sixteen members of...ble form whereas MT-MMPs exist as integral membran...s MMP14, MMP15, MMP16 respectively contain a C-ter...ell surface. They have an 8 amino acid insert in t...
CD43 MicroBeads, rat from Miltenyi Biotec
...isperser System from IKA Works is the worlds first...safer, and more efficient way to disperse samples....2 to 15 ml inside sealed tubes. Depending on their...erent tube types. Each tube is hermetically sealed...
Biology Products: